Zydus Lifesciences: Announcement under Regulation 30 (LODR)-Press Release / Media Release | Value Research

Zydus Lifesciences: Announcement under Regulation 30 (LODR)-Press Release / Media Release

Zydus receives final approval from USFDA and 180 days shared exclusivity for Brivaracetam Tablets

Click here to view PDF


Other Categories